Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(18 sites)
United States
Research Site, Phoenix, Arizona Research Site, San Francisco, California Research Site, Tampa, Florida Research Site, Boston, Massachusetts Research Site, Detroit, Michigan Research Site, Rochester, Minnesota Research Site, St Louis, Missouri Research Site, New York, New York Research Site, New York, New York Research Site, New York, New York Research Site, Cleveland, Ohio Research Site, Nashville, Tennessee Canada
Research Site, Calgary, Alberta Research Site, Calgary, Alberta Research Site, Toronto, Ontario Research Site, Toronto, Ontario